key: cord-1024672-i57nlm9g
authors: Bongetta, Daniele; Calloni, Tommaso; Colombo, Elena Virginia; Versace, Alessandro; Assietti, Roberto
title: Do Matrix Metalloproteases mediate the SARS-CoV-2-related damage to the Central Nervous System?
date: 2020-05-21
journal: Brain Behav Immun
DOI: 10.1016/j.bbi.2020.05.050
sha: 8514bd551feb73be32891f7c570254bcf4c8b09c
doc_id: 1024672
cord_uid: i57nlm9g

nan

Daniele Bongetta MD, PhD 1 , Tommaso Calloni MD 2 We have read with great interest the article "Nervous system involvement after infection with COVID-19 and other coronaviruses" by Wu at al. The Authors are to be commended for their timely review of the possible mechanisms of damage to the nervous system by coronaviruses.

More specifically, the Authors outlined four potential mechanism of injury, the first being related to a direct infection via either a hematogenous or neuronal pathway. In this regard, we would like to highlight the fact that many pathological mechanisms reported by the Authors have been linked to the effects of Matrix metalloproteases (MMPs), enzymes that participate in remodeling the extracellular matrix (ECM). Even more interestingly, a significant MMP overexpression has already been reported in a murine model of encephalitis caused by a coronavirus. [5] For instance, concerning the "blood circulation pathway", the Authors described the relevant role of Blood-brain barrier dysregulation (BBB). In this regard, Rempe et al. recently reviewed the fundamental contribution of MMP upregulation to BBB malfunction, with implications not only on infectious diseases but also on both stroke, epilepsy, Alzheimer's and Parkinson's diseases. [3] Furthermore, the Authors also described the mechanism of local release of interleukines , just as other studies in literature have already established the role played by MMPs in mediating bacterial invasion, neutrophil infiltration as well as the cytokine signaling in neuroinfectious diseases. [2] When dealing instead with the "neuronal pathway", Wu et al. described a demyelination mechanism. In this regard, MMPs have been shown to digest myelin basic protein, thus causing demyelination both in animal models and human tissue. [2] Moreover, the recent rise in the incidence of Kawasaki disease may further support the conjecture of a SARS-CoV-2 tissue damage mediated by MMPs. [4] As a matter of fact, Kawasaki disease has already been linked to coronavirus infections and is strongly related to a viral induced epigenetic overexpression of MMP-9. [1] Since MMPs can have multiple effects on the ECM of different tissues, it is of relevance that their upregulation may not exhaust its effect in the acute setting. This raises the question of the potential long-term MMPs-mediated effects of SARS-CoV-2 infection on CNS tissues. For instance, it is already well known that MMPs (and in particular MMP-9) contribute to both formation, growth, and rupture of cerebral aneurysms by digesting the ECM, which leads to ballooning of blood vessels. [3] Hence, continuous monitoring for potential mid-and long-term pathological effects on the CNS related to the SARS-CoV-2 infection is advised.

Epigenetic hypomethylation and upregulation of matrix metalloproteinase 9 in Kawasaki disease

MMPs and ADAMs in neurological infectious diseases and multiple sclerosis

Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers

An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study

Expression of matrix metalloproteinases and their tissue inhibitor during viral encephalitis